WebFeb 1, 2012 · Brain metastases (BM) from hepatocellular carcinoma (HCC) are extremely rare and are associated with a poor prognosis. The aim of this study was to define clinical outcome and prognostic determinants in patients with BM from HCC. Between January 1994 and December 2009, all patients with HCC and BM treated in Sun Yat-sen … WebJul 17, 2013 · We report on two cases of hepatocellular carcinoma (HCC) with metastasis to the cavernous sinus and sphenoid sinus. Both cases presented with diplopia and retro-orbital headache and both underwent surgery for a primary pituitary gland tumor. After surgery, both cases were diagnosed with metastases from HCC. Case 1 was a 67-year …
Malignant Neoplasm: What It Is, Types & Factors - Cleveland Clinic
WebAug 1, 2024 · Background. Brain metastases (BMs) from hepatocellular carcinoma (HCC) are rare, with a paucity of reported cases. In the present retrospective cohort report, we … WebApr 10, 2024 · The most frequent hepatocellular carcinoma (HCC) metastases sites are, in descending order, lung, peritoneum, bone, spleen, adrenal gland, brain, pleura and kidneys. 1 In addition, unusual... pipe joining sleeves
IJMS Free Full-Text Peroxisome Proliferator-Activated Receptor γ ...
WebOct 23, 2008 · Hepatocellular carcinoma (HCC) is one of the most common cancers in the world and its incidence is increasing [1, 2].Because Korea is an area of endemic Hepatitis B virus, HCC is the third most common cancer and the third cause of cancer deaths in Korea [].Brain metastases are the most common intracranial neoplasm in adults and represent … WebJul 23, 2014 · The aim of this study is to evaluate prognostic factors of brain metastases from hepatocellular carcinoma. Medical records of 95 patients who have been diagnosed of brain metastases from hepatocellular carcinoma between January 2000 and December 2011 were retrospectively reviewed. The median age at diagnosis of brain … WebApr 7, 2024 · Recurrent HCC treatment represented by resection, ablation and TACE is difficult to achieve more satisfactory efficacy. As a local treatment for liver cancer, RFA has the risk of incomplete ablation and insufficient ablation margin, and because RFA cannot resolve micrometastases, tumor growth, invasion and metastasis occur. pipe key